艾德生物：公司部分伴随诊断产品已在日本、韩国等国家获批上市，并纳入当地医保

Core Insights - The company has successfully launched some of its companion diagnostic products in Japan and South Korea, which have also been included in local health insurance systems [2]. Group 1 - The company confirmed that certain companion diagnostic products, such as ROS1, PCR11 gene, and FGFR2, have received approval for sale in Japan and South Korea [2].